한의 임상 연구에 대한 국내외 제언 고찰 - 미래 임상 연구 전략 Ⅱ -
Study on the Proposals for Clinical Research in Korean Medicine Worldwide - Future Clinical Research Strategy Ⅱ -
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
The purpose of this paper is to explore the strategy of future Korean medicine(KM) clinical research through the study on the proposals for KM clinical research worldwide. In this study, the papers published in English through Pubmed were investigated mainly. Among them, we analyzed the methodological proposals from the clinical research papers that were published in the KM related fields. Various proposals for improving the problems in KM clinical studies are as follows. First, KM clinical research should be designed based on understanding for the theory, backgrounds, paradigms and worldviews of KM. In addition, considering the model validity, KM clinical research model should include the diagnosis, interventions and outcomes measurement methods reflecting the characteristics and real practice in KM. The internal validity and external validity should be also taken into account. One of the most important thing is to identify the contents about various and complex 'real practice' in KM. A prospective observational study was suitable for the purpose of this study. Finally, we suggested a few improvement directions for RCTs studies in KM. First, we would be able to improve the quality and the internal validity in KM clinical research using the checklists of CONSORT(Consolidated Standards for Reporting Trials) Statement and STRICTA(Standards for Reporting Interventions in Clinical Trials of Acupuncture). Second, we could use various clinical research methods and the modified research of RCTs such as PCT(pragmatic clinical trial) to reflect the characteristics of actual KM practice. Consequently, we would be able to improve the external validity. Third, the KM diagnosis and outcomes measurement methods should be developed based on an actual KM practice and it should reflect a real practice. The 'pattern identification(辨證)' is the core to KM diagnosis. But in order to be applied to the clinical research, the pattern identification(辨證) should be objectified and standardized. Future KM clinical research model should reflect the characteristics and a real practice in KM. In addition, it should include the advantage of rigorous RCTs research. Specially, the diagnosis, interventions and outcomes measurement methods in KM clinical research should reflect this view.
Abstract
The purpose of this paper is to explore the strategy of future Korean medicine(KM) clinical research through the study on the proposals for KM clinical research worldwide. In this study, the papers published in English through Pubmed were investigated mainly. Among them, we analyzed the methodological proposals from the clinical research papers that were published in the KM related fields. Various proposals for improving the problems in KM clinical studies are as follows. First, KM clinical research should be designed based on understanding for the theory, backgrounds, paradigms and worldviews of KM. In addition, considering the model validity, KM clinical research model should include the diagnosis, interventions and outcomes measurement methods reflecting the characteristics and real practice in KM. The internal validity and external validity should be also taken into account. One of the most important thing is to identify the contents about various and complex 'real practice' in KM. A prospective observational study was suitable for the purpose of this study. Finally, we suggested a few improvement directions for RCTs studies in KM. First, we would be able to improve the quality and the internal validity in KM clinical research using the checklists of CONSORT(Consolidated Standards for Reporting Trials) Statement and STRICTA(Standards for Reporting Interventions in Clinical Trials of Acupuncture). Second, we could use various clinical research methods and the modified research of RCTs such as PCT(pragmatic clinical trial) to reflect the characteristics of actual KM practice. Consequently, we would be able to improve the external validity. Third, the KM diagnosis and outcomes measurement methods should be developed based on an actual KM practice and it should reflect a real practice. The 'pattern identification(辨證)' is the core to KM diagnosis. But in order to be applied to the clinical research, the pattern identification(辨證) should be objectified and standardized. Future KM clinical research model should reflect the characteristics and a real practice in KM. In addition, it should include the advantage of rigorous RCTs research. Specially, the diagnosis, interventions and outcomes measurement methods in KM clinical research should reflect this view.
참고문헌 (42)
- Shea, J.L., "Applying evidence-based medicine to traditional chinese medicine: debate and strategy", J Altern Complement Med, 12(3), pp.255~263 (2006)
- Ernst, E., "Methodological aspects of Traditional Chinese Medicine(TCM)", Ann Acad Med Singapore, 35(11), pp.773~774 (2006)
- Leung, P.C., "A practical way of research in Chinese medicine", Ann Acad Med Singapore, 35(11), pp.770~772 (2006)
- Verhoef, M. J., "Assessing efficacy of complementary medicine: adding qualitative research methods to the "Gold Standard"", J Altern Complement Med, 8(3), pp.275~281 (2002)
- Jiang, M., "Clinical studies with traditional Chinese medicine in the past decade and future research and development", Planta Med, 76(17), pp.2048~2064 (2010)
- Watanabe, K., "Traditional Japanese Kampo Medicine: Clinical Research between Modernity and Traditional Medicine-The State of Research and Methodological Suggestions for the Future", Evid Based Complement Alternat Med, 2011, pp.513842~ (2011)
- 정기용, "한의 임상 연구에 대한 국내외 현황 및 논쟁에 관한 고찰 - 미래 임상 연구 전략 Ⅰ-", 동의생리병리학회지, 28(2), pp.137~145 (2014), 한의병리학회
- Fønnebø, V., "Researching complementary and alternative treatments-the gatekeepers are not at home", BMC Med Res Methodol, 11(7), pp.7~ (2007)
- Cochrane, S., "Looking outside the square: the use of qualitative methods within complementary and alternative medicine: the movement towards rigour", Complement Ther Med, 21(1), pp.73~76 (2013)
- Porzsolt Franz, Eisemann. M., "Complementary alternative medicine and conventional medicine should use identical rules to complete clinical trials", Eur J Integr Med, 2(1), pp.3~7 (2010)
- Mason, S., "Evaluating complementary medicine: methodological challenges of randomised controlled trials", BMJ, 325(7368), pp.832~834 (2002)
- Carter, B., "Methodological issues and complementary therapies: researching intangibles?", Complement Ther Nurs Midwifery, 9(3), pp.133~139 (2003)
- Verhoef, M. J., "Complementary and alternative medicine whole systems research: beyond identification of inadequacies of the RCT", Complement Ther Med, 13(3), pp.206~212 (2005)
- Yan, J., "Study designs of randomized controlled trials not based on Chinese medicine theory are improper", Chin Med, 2009(4), pp.3~ (2009)
- Tang, J.L., "Research priorities in traditional Chinese medicine", BMJ, 333(7564), pp.391~394 (2006)
- Tang, J. L., "An efficacy-driven approach to the research and development of traditional Chinese medicine", Hong Kong Med J, 7(4), pp.375~380 (2001)
- "methodological issues in investigations of massage/bodywork therapy" (2002)[URL]
- MacPherson, H., "Pragmatic clinical trials", Complement Ther Med, 12(2-3), pp.136~140 (2004)
- Godwin, M., "Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity", BMC Med Res Methodol, 22(3), pp.28~ (2003)
- Firenzuoli, F., "Herbal medicine today: clinical and research issues", Evid Based Complement Alternat Med, 4(Suppl 1), pp.37~40 (2007)
- Cardini, F., "Clinical research in traditional medicine: priorities and methods", Complement Ther Med, 14(4), pp.282~287 (2006)
- Nahin, R. L., "Research into complementary and alternative medicine: problems and potential", BMJ, 322(7279), pp.161~164 (2001)
- Moher, D., "Consolidated Standards of Reporting Trials Group. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials", J Clin Epidemiol, 63(8), pp.e1~e37 (2010)
- Sikorskii, A., "Methodological issues in trials of complementary and alternative medicine interventions", Nurs Res, 58(6), pp.444~451 (2009)
- Gagnier, J. J., "Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement", Ann Intern Med, 144(5), pp.364~367 (2006)
- MacPherson, H., "Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement", Acupunct Med, 28(2), pp.83~93 (2010)
- Zwarenstein, M., "Improving the reporting of pragmatic trials: an extension of the CONSORT statement", BMJ, 337, pp.a2390~ (2008)
- Bower, P., "Patient preferences in randomised controlled trials: conceptual framework and implications for research", Soc Sci Med, 61(3), pp.685~695 (2005)
- Li, J., "N-of-1 trials in China", Complement Ther Med, 21(3), pp.190~194 (2013)
- Johnston, B. C., "n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation", J Altern Complement Med, 10(6), pp.979~984 (2004)
- Broom, A., "Current issues and future directions in complementary and alternative medicine (CAM) research", Complement Ther Med, 15(3), pp.217~220 (2007)
- Schnyer, R. N., "Development of a Chinese medicine assessment measure: an interdisciplinary approach using the delphi method", J Altern Complement Med, 11(6), pp.1005~1013 (2005)
- Berle, C. A., "A novel approach to evaluate Traditional Chinese Medicine treatment outcomes using pattern identification", J Altern Complement Med, 16(4), pp.357~367 (2010)
- Critchley, J. A., "Alternative therapies and medical science: designing clinical trials of alternative", complementary medicines is evidence-based traditional Chinese medicine attainable?, 2000, pp.40(5), 462~467
- Long, A.F., "Outcome measurement in complementary and alternative medicine: unpicking the effects", J Altern Complement Med, 8(6), pp.777~786 (2002)
- Sikorskii, A., "Methodological issues in trials of complementary and alternative medicine interventions", Nurs Res, 58(6), pp.444~451 (2009)
- Eton, D. T., "Patient-reported outcomes in studies of complementary and alternative medicine: problems, solutions, and future directions", Explore (NY), 7(5), pp.314~319 (2011)
- Calvert, M., "The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice", Health Qual Life Outcomes, 11, pp.184~ (2013)
- Leung, K. F., "Development and validation of the Chinese Quality of Life Instrument", Health Qual Life Outcomes, 3, pp.26~ (2005)
- Efficace, F., "Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology", J Clin Epidemiol, 59(12), pp.1257~1265 (2006)
- Zhang, L., "Clinical Research of Traditional Chinese Medicine Needs to Develop Its Own System of Core Outcome Sets", Evid Based Complement Alternat Med, 2013, pp.202703~ (2013)
- Normile, D., "Asian medicine. The new face of traditional Chinese medicine", Science, 299(5604), pp.188~190 (2003)
